// App-Quantinova.ai

FRI0315 : GENDER DIFFERENCES IN PATIENT JOURNEY TO DIAGNOSIS AND PATIENT-REPORTED OUTCOMES: RESULTS FROM THE EUROPEAN MAP OF AXIAL SPONDYLOARTHRITIS (EMAS)

Researchers

Presenter

  • M. Garrido-Cumbrera

Principal Investigators

  • D. Poddubnyy

  • L. Gossec

  • R. Mahapatra

  • C. Bundy

  • S. Makri

  • S. Sanz-Gomez

  • L. Christen

  • C. J. Delgado-Domnguez

  • V. Navarro-Compn

Medical Centers

  • Health & Territory Research, Universidad de Sevilla, Seville, Spain, Sevilla

  • Spanish Federation of Spondyloarthritis Associations (CEADE), Presidency, Madrid, Spain

  • Charite Univsmedizin Berlin, Berlin, Germany

  • German Rheumatism Research Centre, Berlin, Germany

  • Sorbonne Universites, Paris, France

  • University Hospitals Pitié Salpêtrière - Charles Foix, Rheumatology, Paris, France

  • Axial Spondyloarthritis International Federation (ASIF), London, United Kingdom

  • Cardiff University, Cardiff, United Kingdom

  • Cyprus League Against Rheumatism, Nicosia, Cyprus

  • Novartis AG, Basel, Switzerland

  • University Hospital La Paz, Madrid, Spain

Locations

  • Spain

  • Germany

  • France

  • United Kingdom

  • Cyprus

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Axial spondyloarthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Novartis Pharma

Result

  • N/A